King SJ - Search Results

1

Reduced bone density in cystic fibrosis: DeltaF508 mutation is an independent risk factor.

King SJ, Topliss DJ, Kotsimbos T, Nyulasi IB, Bailey M, Ebeling PR, Wilson JW. King SJ, et al. Eur Respir J. 2005 Jan;25(1):54-61. doi: 10.1183/09031936.04.00050204. Eur Respir J. 2005. PMID: 15640323 Free article.

2

Body composition assessment in adults with cystic fibrosis: comparison of dual-energy X-ray absorptiometry with skinfolds and bioelectrical impedance analysis.

King S, Wilson J, Kotsimbos T, Bailey M, Nyulasi I. King S, et al. Nutrition. 2005 Nov-Dec;21(11-12):1087-94. doi: 10.1016/j.nut.2005.04.005. Epub 2005 Sep 23. Nutrition. 2005. PMID: 16183254

3

Intravenous zoledronate improves bone density in adults with cystic fibrosis (CF).

Chapman I, Greville H, Ebeling PR, King SJ, Kotsimbos T, Nugent P, Player R, Topliss DJ, Warner J, Wilson JW. Chapman I, et al. Among authors: king sj. Clin Endocrinol (Oxf). 2009 Jun;70(6):838-46. doi: 10.1111/j.1365-2265.2008.03434.x. Epub 2008 Sep 24. Clin Endocrinol (Oxf). 2009. PMID: 18823395 Clinical Trial.

4

Tachycardia in adults with cystic fibrosis is associated with normal autonomic function.

Szollosi I, King SJ, Wilson JW, Naughton MT. Szollosi I, et al. Among authors: king sj. Intern Med J. 2011 Jun;41(6):455-61. doi: 10.1111/j.1445-5994.2009.02039.x. Epub 2009 Aug 27. Intern Med J. 2011. PMID: 19712204

5

Fat-free mass depletion in cystic fibrosis: associated with lung disease severity but poorly detected by body mass index.

King SJ, Nyulasi IB, Strauss BJ, Kotsimbos T, Bailey M, Wilson JW. King SJ, et al. Nutrition. 2010 Jul-Aug;26(7-8):753-9. doi: 10.1016/j.nut.2009.06.026. Nutrition. 2010. PMID: 19931415

6

Loss of fat-free mass over four years in adult cystic fibrosis is associated with high serum interleukin-6 levels but not tumour necrosis factor-alpha.

King SJ, Nyulasi IB, Bailey M, Kotsimbos T, Wilson JW. King SJ, et al. Clin Nutr. 2014 Feb;33(1):150-5. doi: 10.1016/j.clnu.2013.04.012. Epub 2013 Apr 24. Clin Nutr. 2014. PMID: 23664115

7

The activin A antagonist follistatin inhibits cystic fibrosis-like lung inflammation and pathology.

Hardy CL, King SJ, Mifsud NA, Hedger MP, Phillips DJ, Mackay F, de Kretser DM, Wilson JW, Rolland JM, O'Hehir RE. Hardy CL, et al. Among authors: king sj. Immunol Cell Biol. 2015 Jul;93(6):567-74. doi: 10.1038/icb.2015.7. Epub 2015 Mar 10. Immunol Cell Biol. 2015. PMID: 25753271 Free PMC article.

8

Evaluating the impact of 2006 Australasian Clinical Practice Guidelines for nutrition in children with cystic fibrosis in Australia.

Ruseckaite R, Pekin N, King S, Carr E, Ahern S, Oldroyd J, Earnest A, Wainwright C, Armstrong D. Ruseckaite R, et al. Respir Med. 2018 Sep;142:7-14. doi: 10.1016/j.rmed.2018.07.007. Epub 2018 Jul 19. Respir Med. 2018. PMID: 30170805 Free article.

9

Measured Energy Expenditure Compared With Best-Practice Recommendations for Obese, Critically Ill Patients-A Prospective Observational Study.

Ridley EJ, Tierney A, King S, Ainslie E, Udy A, Scheinkestel C, Nyulasi I. Ridley EJ, et al. JPEN J Parenter Enteral Nutr. 2020 Aug;44(6):1144-1149. doi: 10.1002/jpen.1791. Epub 2020 Feb 6. JPEN J Parenter Enteral Nutr. 2020. PMID: 32030772

10

Redesign of the Australian Cystic Fibrosis Data Registry: A multidisciplinary collaboration.

Ahern S, Dean J, Liman J, Ruseckaite R, Burke N, Gollan M, Keatley L, King S, Kotsimbos T, Middleton PG, Schultz A, Wainwright C, Wark P, Bell S. Ahern S, et al. Paediatr Respir Rev. 2021 Mar;37:37-43. doi: 10.1016/j.prrv.2020.03.001. Epub 2020 Mar 26. Paediatr Respir Rev. 2021. PMID: 32331762 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

242 results

Search Page

Filters